Search Results 1491-1500 of 19639 for autoimmune hepatitis

  1. Pancreatitis - Symptoms and causes - Mayo Clinic

    Sleisenger and Fordtran's Gastrointestinal and Liver Disease: Pathophysiology, Diagnosis, Management. 11th ed. Elsevier; 2021. https://www.clinicalkey.com ...

  2. Ruxolitinib (oral route) - Mayo Clinic

    Liver disease (eg, hepatitis B) or; Neutropenia (low number of white blood cells) or; Skin cancer, history of or; Thrombocytopenia (low number of platelets) or ...

  3. Primary immunodeficiency - Diagnosis & treatment - Mayo Clinic

    In some cases, primary immune disorders are linked to a serious illness, such as an autoimmune disorder or cancer, which also needs to be treated. Managing ...

  4. Desvenlafaxine (oral route) - Mayo Clinic

    Liver disease, moderate to severe—Use with caution. The effects may be increased because of slower removal of the medicine from the body. Back to top. Proper ...

  5. Estrogen (vaginal route) - Mayo Clinic

    Liver disease or; Liver problems—Estrogens should not be used. Lupus erythematosus, systemic (SLE or lupus)—Estrogens may worsen this medical problem ...

  6. Thyroid Disease Clinical Trials

    Control patients will be those with thyroid nodules as well as autoimmune thyroid disease, with and without exposure to ICI. Placental Deiodinase Activity ...

  7. Dextromethorphan and quinidine (oral route) - Side effects & dosage - Mayo Clinic

    Hepatitis caused by quinidine, quinine, or mefloquine, history of or; Lupus ... Liver disease, severe—Higher blood levels of this medicine can occur ...

  8. Ipilimumab (intravenous route) - Mayo Clinic

    Autoimmune disease (eg, Crohn disease, lupus, sarcoidosis, ulcerative ... Hepatitis (inflammation of the liver) or; Hyperthyroidism (overactive thyroid) ...

  9. Amlodipine, valsartan, and hydrochlorothiazide (oral route) - Mayo Clinic

    Liver disease—Use with caution. The effects may be increased because of slower removal of the medicine from the body. Back to top ...

  10. Gastroenterology and Hepatology - Clinical trials

    Resolution of NASH is defined as non-alcoholic fatty liver disease (NAFLD) activity score (NAS) of 0–1 for inflammation, 0 for ballooning, and any other value ...